Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.180
-0.040 (-3.28%)
Oct 28, 2025, 3:12 PM EDT - Market open
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $115.05 million as of October 28, 2025. Its market cap has decreased by -18.18% in one year.
Market Cap
115.05M
Enterprise Value
102.15M
1-Year Change
-18.18%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $115.05M, an increase of 64.90%. That is a compound annual growth rate of 7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 115.05M | 9.65% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | 71.68M | -21.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.59B |
| Johnson & Johnson | 453.63B |
| AbbVie | 402.30B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 222.64B |